article thumbnail

STAT+: Diagnosed with cancer, a pharmaceutical executive became a patient advocate and changed drug development. It took decades

STAT

Her book, “ Fatal to Fearless ,” was blurbed by everyone from newsman Tom Brokaw to research scientist Eric Topol. Thanks in part to better treatments that help patients stay alive, the number of people in the U.S. who live with myeloma has increased 80% to 180,000.

article thumbnail

Is the future of AI in health care just a lot of hype?

STAT

student Kapoor to publish the book “ AI Snake Oil ,” which came out Sep. While the book encourages skepticism about many AI claims, the pair consider themselves cautiously optimistic about the future of the technology — including as it pertains to health care. Now he’s teamed up with his Ph.D.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

STAT+: Even as Wegovy rides high, interest surges in weight loss drugs that preserve muscle

STAT

Have you ever seen a mouse with a set of muscles more appropriate for a bodybuilder or comic book superhero? Well, 25 years ago, researchers at Johns Hopkins University made it happen.

article thumbnail

One firm, two conflicting takes on Alnylam’s HELIOS-B 

STAT

Today, STAT published our  annual list of the top books and podcasts  to check out this summer. Want to stay on top of the science and politics driving biotech today?    Sign up  to get our biotech newsletter in your inbox. Good morning.

article thumbnail

We now know Tome’s gene editing target

STAT

Today we learn whether AI might help hasten the development of n-of-1 therapies (hint: not yet), explore why the FDA hasn’t offered Orange Book guidance on drug-device combinations, and talk about CRISPR.   Sign up  to get our biotech newsletter in your inbox. Read the rest…

article thumbnail

Innovative Strategies in Drug Repurposing

Drug Patent Watch

Drug repurposing, or identifying new therapeutic uses for existing drugs, is gaining significant momentum as a promising approach to accelerate drug development and reduce costs. This book chapter provides a… Source

article thumbnail

NHC and EveryLife Foundation for Rare Diseases PFDD Guidance Book Club

Putting Patients First Blog

NHC and EveryLife Foundation for Rare Diseases PFDD Guidance Book Club Event Time: 3:00 - 4:00 p.m. ET for an in-depth discussion of the FDA’s fourth guidance on patient-focused drug development (PFDD). The post NHC and EveryLife Foundation for Rare Diseases PFDD Guidance Book Club appeared first on National Health Council.